Clinical Trial Update: A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating hetrombopag olamine for chronic immune thrombocytopenia (idiopathic thrombocytopenic purpura).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Hetrombopag (hetrombopag)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Purpura, Thrombocytopenic, Idiopathic | Phase 1 | Status: UNKNOWN